# An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

> **NCT00652080** · PHASE1,PHASE2 · COMPLETED · sponsor: **BPGbio** · enrollment: 35 (actual)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DRUG:** API 31510

## Key facts

- **NCT ID:** NCT00652080
- **Lead sponsor:** BPGbio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00652080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00652080, "An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00652080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*